Our latest Investor Newsletter is here.
This edition includes an update from Patrys CEO and MD, Dr James Campbell; a feature about how antibodies work and why they’re such a compelling focus for our research; an intellectual property overview; a closer look at recent funding from Cure Brain Cancer Foundation; and insight into the unique skills of our expanding team.